We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » E&C Committee Reviews 340B Drug Pricing Program, Offers Recommendations
E&C Committee Reviews 340B Drug Pricing Program, Offers Recommendations
The House Energy and Commerce Committee released a review of the 340B drug discount pricing program, identifying weaknesses in oversight and administration, among other issues, and offering recommendations to resolve them.